Ginolis announces delivery of first LFDA-3 to Suzhou Dingshi Medical Technology in China

NewsGuard 100/100 Score

Ginolis Ltd, a global desktop automation and liquid handling solutions provider, today announced the delivery of the first LFDA-3 to Suzhou Dingshi Medical Technology company in China. The revolutionary rapid test assembly solution provides manufacturers flexible production capacity within a desktop footprint.

“The new modular compact LFDA-3 went beyond all our expectations. We are very happy with the system and the cooperation with Ginolis.” states Dingshi CEO Alex Xi. “They have been professional and accommodated all our needs. We are looking forward to going further with Ginolis.”

The innovative lateral flow device assembly solution provides high volume production capacity with automated visual inspection and guidance ensuring the highest standard of quality control. The LFDA-3 solution is easily adaptable and can assemble different rapid tests with minimal product specific adjustments.

“The first LFDA-3 system delivery was a great success. Dingshi has been a great partner and we look forward working with them in the future” states VP Sales and Marketing, Jorma Venäläinen. “This is a very important step for us moving forward in the Asia Pacific market. We feel that there is huge growth potential for Ginolis’ solutions in Asia and this deal is a testament to that.”

The total value of the deal is not disclosed.

The company will be showcasing the LFDA-3 at the Medica tradeshow in Düsseldorf, Germany on November 14 – 17, 2016. Visit Ginolis Ltd at Hall 1 stand B15.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
How do different people define 'healthy eating'?